Minimally invasive liver surgery for metastases from colorectal cancer: Oncologic outcome and prognostic factors

Surgical Endoscopy

Volumn 26, Issue 8, 2012, Pages 2288-2298

  Topal, Baki ^a   Tiek, Joyce ^a   Fieuws, Steffen ^a   Aerts, Raymond ^a   Van Cutsem, Eric ^a   Roskams, Tania ^a   Prenen, Hans ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Colorectal liver metastases; Minimally invasive surgery; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; FONG CLINICAL RISK SCORE; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; LIVER METASTASIS; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 84864064938     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-012-2176-9     Document Type: Article

References (22)

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318
2. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766
3. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715-722
4. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575-4580
5. Topal B, Fieuws S, Aerts R, Vandeweyer H, Penninckx F (2008) Laparoscopic vs. open liver resection of hepatic neoplasms; comparative analysis of short-term results. Surg Endosc 22:2208-2213
6. Rocha FG, D'Angelica M (2010) Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol 102:968-974
7. Nguyen KT, Geller DA (2010) Outcomes of laparoscopic hepatic resection for colorectal cancer metastases. J Surg Oncol 102:975-977
8. Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ (2006) Radiofrequency ablation of liver tumours: a systematic review. Arch Surg 141:181-190
9. Nguyen KT, Laurent A, Dagher I, Geller DA, Steel J, Thomas MT, Marvin M, Ravindra KV, Mejia A, Lainas P, Franco D, Cherqui D, Buell JF, Gamblin TC (2009) Minimally invasive liver resection for metastatic colorectal cancer. A multi-institutional, international report of safety, feasibility, and early outcomes. Ann Surg 250:842-848
10. Castaing D, Vibert E, Ricca L, Azoulay D, Adam R, Gayet B (2009) Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centres. Ann Surg 250:849-855
11. Sasaki A, Nitta H, Otsuka K, Takahara T, Nishizuka S, Wakabayashi G (2009) Ten-year experience of totally laparoscopic liver resection in a single institution. Br J Surg 96:274-279
12. Kazaryan AM, Marangos IP, Røsok BI, Rosseland AR, Villanger O, Fosse E, Mathisen O, Edwin B (2010) Laparoscopic resection of colorectal liver metastases. Surgical and long-term oncologic outcome. Ann Surg 252:1005-1012
13. Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15:144-157
14. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
15. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6, 336 patients and results of a survey. Ann Surg 240:214-215
16. Lin D, Wei L, Ying Z (1993) Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika 80:557-572
17. Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D'Angelica M (2007) The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 246:295-300
18. Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B, Vecchio FM (2008) Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-centre experience. Surgery 143:384-393
19. De Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248:626-637
20. Lordan JT, Karanjia ND (2010) 'Close Shave' in liver resection for colorectal metastases. Eur J Surg Oncol 36:47-51
21. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L (2005) Local recurrence after hepatic radiofrequency coagulation. Multivariate meta-analysis and review of contributing factors. Ann Surg 242:158-171
22. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T, EORTC Gastro-Intestinal Tract Cancer Group, Cancer Research UK, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO), Australasian Gastro-Intestinal Trials Group (AGITG), Fédération Francophone de Cancérologie Digestive (FFCD) (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007-1016